HomeCompareTRUMY vs PLD

TRUMY vs PLD: Dividend Comparison 2026

TRUMY yields 1.39% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $5.33M in total portfolio value
10 years
TRUMY
TRUMY
● Live price
1.39%
Share price
$13.70
Annual div
$0.19
5Y div CAGR
75.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$581.3K
Annual income
$384,516.52
Full TRUMY calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — TRUMY vs PLD

📍 PLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTRUMYPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TRUMY + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TRUMY pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TRUMY
Annual income on $10K today (after 15% tax)
$117.88/yr
After 10yr DRIP, annual income (after tax)
$326,839.04/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, PLD beats the other by $3,711,277.37/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TRUMY + PLD for your $10,000?

TRUMY: 50%PLD: 50%
100% PLD50/50100% TRUMY
Portfolio after 10yr
$3.24M
Annual income
$2,567,620.85/yr
Blended yield
79.13%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

TRUMY
No analyst data
Altman Z
4.2
Piotroski
7/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TRUMY buys
0
PLD buys
0
No recent congressional trades found for TRUMY or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTRUMYPLD
Forward yield1.39%3.10%
Annual dividend / share$0.19$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR75.5%74.4%
Portfolio after 10y$581.3K$5.91M
Annual income after 10y$384,516.52$4,750,725.19
Total dividends collected$542.2K$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: TRUMY vs PLD ($10,000, DRIP)

YearTRUMY PortfolioTRUMY Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$10,943$243.39$11,241$540.96$298.00PLD
2$12,146$436.87$13,019$991.13$873.00PLD
3$13,792$795.32$15,801$1,870.97$2.0KPLD
4$16,238$1,481.20$20,609$3,701.21$4.4KPLD
5$20,236$2,860.42$29,919$7,867.97$9.7KPLD
6$27,499$5,846.46$50,631$18,617.74$23.1KPLD
7$42,455$13,031.07$105,528$51,352.20$63.1KPLD
8$78,424$32,998.00$287,364$174,449.42$208.9KPLD
9$183,893$99,978.77$1,081,760$774,280.77$897.9KPLD
10$581,282$384,516.52$5,908,209$4,750,725.19$5.33MPLD

TRUMY vs PLD: Complete Analysis 2026

TRUMYStock

Terumo Corporation engages in the manufacture and sale of medical products and equipment worldwide. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management and nutritious food products, adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan.

Full TRUMY Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this TRUMY vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TRUMY vs SCHDTRUMY vs JEPITRUMY vs OTRUMY vs KOTRUMY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.